<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127712">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01850875</url>
  </required_header>
  <id_info>
    <org_study_id>01EC1010A</org_study_id>
    <nct_id>NCT01850875</nct_id>
  </id_info>
  <brief_title>Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain</brief_title>
  <acronym>LOGIN - EMDR</acronym>
  <official_title>Localized and Generalized Musculoskeletal Pain: Psychobiological Mechanisms and Implications for Treatment (LOGIN) - Subgroups Characterized by Psychological Trauma, Mental Comorbidity, and Psychobiological Patterns and Their Specialized Treatment - Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <authority>Germany: Federal Ministry of Education and Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study explores the feasibility of Eye-Movement-Desensitization and Reprocessing (EMDR)
      in non-specific chronic back pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study explores the feasibility of Eye-Movement-Desensitization and Reprocessing (EMDR)
      in non-specific chronic back pain in a randomized controlled trial (RCT) with 6 months
      follow-up. The treatment consists of 12-sessions EMDR a 60 minutes using eye-movements for
      bilateral stimulation in addition to treatment as usual (TAU) that is compared to TAU alone.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in pain intensity</measure>
    <time_frame>Change from Baseline Pain intensity at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Numerical rating scale 0-10</description>
  </primary_outcome>
  <other_outcome>
    <measure>functional and structural changes in fMRI</measure>
    <time_frame>Change from Baseline fMRI at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change in the pain experience scale - Pain affect</measure>
    <time_frame>Change from Baseline pain experience scale levels at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Geisser et al., 1996</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in the Hannover functional ability questionnaire (FFbH) - disability</measure>
    <time_frame>Change from Baseline disabilty levels at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Kohlmann et al., 1996</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Quantitative sensory testing (QST)profiles</measure>
    <time_frame>Change from Baseline QST profile at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>According to the protocol by Rolke et al. (2006), developed within the Germany Research Network on Neuropathic Pain (DFNS)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Conditioned Pain Modulation</measure>
    <time_frame>Change from Baseline conditioned pain modulation activity at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>difference in pressure pain threshold before and after oscillating heat (2 min.)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Plasma endocannabinoids and lipids</measure>
    <time_frame>Change from Baseline endocannabinoids and lipids at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Plasma levels: AEA (ng/ml), 2-AG (ng/ml), AA (ng/ml), PEA (ng/ml), OEA (ng/ml), AEA (pmol/g), 2-AG (pmol/g), AA (nmol/g), PEA (pmol/g), OEA (pmol/g),</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in plasma nerve growth factor levels</measure>
    <time_frame>Change from Baseline NGF levels at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Plasma levels in (pg/ml)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in pain drawing/ the spatial extent of the pain</measure>
    <time_frame>Change from Baseline Pain extent at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change in West Haven-Yale multidimensional pain inventory scores</measure>
    <time_frame>Change from Baseline West Haven-Yale multidimensional pain inventory scores at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Flor et al., 1990</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in chronic pain grade</measure>
    <time_frame>Change from Baseline chronic pain grade at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>von Korff er al., 1992</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Resilience Scale (RS-11) scores</measure>
    <time_frame>Change from Baseline resilience scores at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Schumacher et al., 2004</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Hospital Anxiety and Depression Scale scores</measure>
    <time_frame>Change from Baseline anxiety and depression levels at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Zigmond &amp; Snaith, 1983</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Health Survey scores</measure>
    <time_frame>Change from baseline quality of life level at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>SF-12</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in somatization scores</measure>
    <time_frame>Change from Baseline somatization scores at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>SCL-90R</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in medication intake</measure>
    <time_frame>Change from Baseline medication intake at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change in dissociation scores</measure>
    <time_frame>Change from Baseline dissociation at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>DES/FDS-20</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Post Traumatic Diagnostic Scale</measure>
    <time_frame>Change from Baseline post traumatic diagnostic scale levels at average 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Patient global impression of change</measure>
    <time_frame>after on average 6 months of treatment</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Recruitment potential</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>% of patients eligible for inclusion that give written informed consent</description>
  </other_outcome>
  <other_outcome>
    <measure>Retention rate</measure>
    <time_frame>over average 6 months of treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>% of patients that finish treatment, including pre- and post-evaluation</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Non-specific Chronic Back Pain</condition>
  <arm_group>
    <arm_group_label>Eye-Movement-Desensitization-Reprocessing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eye-Movement-Desensitization-Reprocessing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual (control group)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>treatment as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Eye-Movement-Desensitization-Reprocessing</intervention_name>
    <arm_group_label>Eye-Movement-Desensitization-Reprocessing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;= 18 years

          -  non-specific chronic low back pain &gt;= 45 days/3 months

          -  high emotional distress caused by psychological trauma

          -  German language skills

        Exclusion Criteria:

          -  specific causes of chronic back pain

          -  application for retirement pension pending

          -  ongoing psychotherapy

          -  severe physical or psychiatric comorbidity
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Eich, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas Gerhardt, Dipl.-Psych.</last_name>
    <phone>+49 6221 5636860</phone>
    <email>andreas.gerhardt@med.uni-heidelberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jonas Tesarz, Dr.</last_name>
    <phone>+49 6221 5637862</phone>
    <email>jonas.tesarz@med.uni-heidelberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonas Tesarz, Dr.</last_name>
      <phone>+49 6221 5637862</phone>
      <email>jonas.tesarz@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Wolfgang Eich, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.login-verbund.de/index.php?id=2&amp;L=1</url>
    <description>Consortium LOGIN</description>
  </link>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 13, 2013</lastchanged_date>
  <firstreceived_date>April 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Wolfgang Eich</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Eye-Movement-Desensitization and Reprocessing</keyword>
  <keyword>EMDR</keyword>
  <keyword>Chronic back pain</keyword>
  <keyword>CBP</keyword>
  <keyword>treatment</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
